| Bio-Engineering of Pre-Vascularized Islet Organoids for the Treatment of Type 1 Diabetes | Transplant international |  | | 2022 | 487 | 483 |
|
| 402.7: Homemade hydrogel from human amniotic membrane improves islet transplantation outcomes in diabetic immunodeficient mice | Transplantation |  | | 2021 | 246 | 2 |
|
| P.169: Decellularized cotyledons isolated from human placenta used like a scaffold for the generation of a human bioartificial pancreas | Transplantation | | | 2021 | 203 | 1 |
|
| Mechanisms of Immunomodulation and Cytoprotection Conferred to Pancreatic Islet by Human Amniotic Epithelial Cells | Stem cell reviews and reports | | | 2021 | 291 | 299 |
|
| 402.5: Human Amniotic Epithelial Cells Immunomodulatory Properties Protect Islets Against Inflammatory Cytokines In Vitro | Transplantation | | | 2021 | 208 | 1 |
|
| Engineering of primary pancreatic islet cell spheroids for three-dimensional culture or transplantation: a methodological comparative study | Cell Transplantation | | | 2020 | 421 | 307 |
|
| Shielding islets with human amniotic epithelial cells enhances islet engraftment and revascularization in a murine diabetes model | American Journal of Transplantation | | | 2020 | 324 | 294 |
|
| Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes | Nature Communications | | | 2019 | 431 | 391 |
|
